Соединенные Штаты - английский - NLM (National Library of Medicine)

eugia us llc - isosulfan blue (unii: 39n9k8s2a4) (isosulfan blue inner salt - unii:ns6q291771) - isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. it is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities. isosulfan blue injection 1% is contraindicated in those individuals with known hypersensitivity to triphenylmethane or related compounds. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isosulfan blue 1% is administered to a nursing mother. safety and effectiveness of isosulfan blue 1% in children have not been established.

Соединенные Штаты - английский - NLM (National Library of Medicine)

somerset therapeutics, llc - isosulfan blue (unii: 39n9k8s2a4) (isosulfan blue inner salt - unii:ns6q291771) - isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. it is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities. isosulfan blue injection 1% is contraindicated in those individuals with known hypersensitivity to triphenylmethane or related compounds. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isosulfan blue injection 1% is administered to a nursing mother. safety and effectiveness of isosulfan blue injection 1% in children have not been established.

Соединенные Штаты - английский - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - isosulfan blue (unii: 39n9k8s2a4) (isosulfan blue inner salt - unii:ns6q291771) - isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. it is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities. isosulfan blue 1% is contraindicated in those individuals with known hypersensitivity to triphenylmethane or related compounds. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isosulfan blue 1% is administered to a nursing mother. safety and effectiveness of isosulfan blue 1% in children have not been established.

Соединенные Штаты - английский - NLM (National Library of Medicine)

anazaohealth corporation - isosulfan blue (unii: 39n9k8s2a4) (isosulfan blue - unii:39n9k8s2a4) - isosulfan blue 10 mg in 1 ml - isosulfan blue 1% injection delineates the lymphatic vessels following subcutaneous administration. it is an adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization to the lymphatic system draining the region of injection hypersensitivity to triphenylmethane or related compounds

Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - cuprous oxide; diuron - paint - cuprous oxide mineral-copper active 460.0 g/l; diuron urea-substituted active 45.0 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats

Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - copper (as copper oxide); diuron - paint - copper (as copper oxide) mineral-copper active 745.0 g/l; diuron urea-substituted active 75.0 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; croscarmellose sodium; maize starch; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 15.2 mg (equivalent: tamoxifen, qty 10 mg) - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; croscarmellose sodium; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Ирландия - английский - HPRA (Health Products Regulatory Authority)

may & baker limited - metronidazole - suppositories - 1 g grams

Ирландия - английский - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited - metronidazole - suppositories - 0.5 grams